JANINE VALLEN: Open Payments
NPI 1730481292 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$996 in 10 payments from 7 companies in 2025. Trend: 2023 $350 · 2024 $961 · 2025 $996
Food & beverage: $996
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 3 | $251 |
| Mallinckrodt Hospital Products Inc. | 2 | $243 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $139 |
| Mirum Pharmaceuticals, Inc. | 1 | $124 |
| Eurofins Viracor, LLC | 1 | $122 |
| Novo Nordisk Inc | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Kerendia, ULTOMIRIS, Livmarli, ACTHAR, TERLIVAZ, Wegovy, FARXIGA.
Industry payments across NJ — which companies pay providers there.
